Gabapentin (brand names Neurontin, Gralise) is a medication originally developed for epilepsy that has found widespread off-label use in psychiatry. It is commonly prescribed for anxiety disorders, insomnia, nerve pain, and as an adjunctive treatment in various psychiatric conditions. While gabapentin is generally well-tolerated, understanding its side effects is important given how frequently it is prescribed.
The most frequently reported side effects of gabapentin include drowsiness and sedation (the most common side effect, which can be therapeutic when used for insomnia but problematic during the day), dizziness and unsteadiness, fatigue, peripheral edema (swelling in ankles and feet), weight gain (averaging 2-3 kg, less than with some other psychiatric medications but not negligible), blurred vision, dry mouth, and cognitive effects ("brain fog," difficulty with word-finding, reduced mental sharpness). Most side effects are dose-dependent — they increase with higher doses and often improve over the first 1-2 weeks as the body adjusts.
Despite limited FDA-approved psychiatric indications, gabapentin is widely prescribed off-label for several conditions. For anxiety, it can reduce both physical and psychological symptoms, working through GABA-related mechanisms distinct from SSRIs and benzodiazepines. For insomnia, its sedating properties make it useful as a sleep aid, particularly when anxiety or pain contributes to sleep difficulties. For alcohol use disorder, gabapentin has growing evidence for reducing cravings and improving sleep during early recovery. It is also used adjunctively for bipolar disorder and PTSD, though evidence for these uses is weaker.
While gabapentin was initially considered to have minimal abuse potential, evidence has emerged that dependence can develop, particularly at higher doses and in patients with a history of substance use disorders. Abrupt discontinuation can cause withdrawal symptoms including anxiety, insomnia, nausea, sweating, and in rare cases, seizures. Always taper gabapentin gradually under your psychiatrist's supervision. Several states have reclassified gabapentin as a controlled substance due to misuse concerns.
A psychiatric evaluation helps determine whether gabapentin is appropriate for your specific situation, considering your diagnosis, substance use history, and other medications.
Unlike gabapentin, benzodiazepines like Ativan (lorazepam) carry significant dependence risk and are generally reserved for short-term use.
SNRIs like Effexor offer broader neurotransmitter coverage than gabapentin and are often considered when anxiety co-occurs with depression.
This content is for informational purposes only and should not replace professional medical advice, diagnosis, or treatment. To discuss gabapentin or medication options, contact Elevate Psychiatry. We serve adults 18 and older through our Miami offices in Coconut Grove and Doral, as well as virtually throughout Florida.
